Ignite Creation Date:
2025-12-24 @ 8:00 PM
Ignite Modification Date:
2026-01-08 @ 6:40 AM
Study NCT ID:
NCT01317004
Status:
COMPLETED
Last Update Posted:
2015-06-22
First Post:
2011-03-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CFTY720DIT02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None